Linking Prenatal Antidepressant Use & Risk of Adverse Neonatal Outcomes

Depression is common among pregnant women and, untreated, is associated with morbidity in both mother and child.

But what about the risks of treatment?

A large database study from the US, with information on the timing, dose, and type of antidepressant treatment in pregnancy, identifies a dose dependent increase in risk for newborn respiratory distress and a small increase in risk of preterm birth in those taking higher doses.

One thought on “Linking Prenatal Antidepressant Use & Risk of Adverse Neonatal Outcomes

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.